OXGN -Presenting at conference Sept 9. Any positive news will send this much higher. Also full data readout in oct/November timeframe.. This will start shooting up when they release abstracts . Few of the small biotechs trading roughly around cash that has posted positive results on ovarian cancer.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.